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The Structural Genomics Consortium
(SGC) is a not-for-profit, public-private
partnership established to deliver novel
structural biology knowledge on proteins of
medical relevance and place this informa-
tion into the public domain without restric-
tion, spearheading the concept of ‘‘Open-
Source Science’’ to enable drug discovery.
The SGC is a major provider of structural
information focussed on proteins related to
human health, contributing 20.5% of novel
structures released by the PDB in 2008. In
this article we describe the PLoS ONE
Collection entitled ‘Structural Biology and
Human Health: Medically Relevant Pro-
teins from the SGC’. This Collection
contains a series of articles documenting
many of the novel protein structures deter-
mined by the SGC and work to further
characterise their function. Each article in
this Collection can be read in an enhanced
version where we have integrated our
interactive and intuitive 3D visualisation
platform, known as iSee. This publishing
platform enables the communication of
complex structural biology and related data
to a wide audience of non-structural biolo-
gists. With the use of iSee as the first
example of an interactive and intuitive 3D
document publication method as part of
PLoS ONE, we are pushing the boundaries
of structural biology data delivery and peer-
review. Our strong desire is that this step
forward will encourage others to consider
the need for publication of three dimension-
al and associated data in a similar manner.
Introduction
Since its advent, structural biology has
played a major role in the understanding
of biological processes at the molecular
level. This, in turn, has enabled the
progression and development of several
fields in biological sciences. As a conse-
quence there has been a continuing
demand for faster and more cost-effective
determination of protein structures and
their in-depth functional, mechanistic and
biological analysis. The lack of a well-
established process historically meant that
structures were been solved in a case-by-
case manner, with academic researchers
establishing specific protocols over a
relatively long period of time that are
difficult to implement or inappropriate for
high-throughput approaches. As the se-
quencing of the human genome was
completed the gap between known genes
and solved protein structures became
wider. As a result concerted and system-
atic technology-driven ‘structural geno-
mics’ (SG) efforts to solve protein struc-
tures in a high throughput manner were
begun (for thorough reviews see [1,2]).
First formalised in 1998 [3–5], several
major SG efforts were subsequently started
such as the NIH-funded Protein Structure
Initiative (PSI; http://www.nigms.nih.
gov/Initiatives/PSI), European initiatives
‘The Protein Structure Factory (PSF;
http://www.proteinstrukturfabrik.de) and
‘Structural Proteomics in Europe (SPINE;
http://www.spineurope.org) and Japanese
Protein 3000 and RIKEN Structural
Genomics/Proteomics programs (http://
protein.gsc.riken.jp). The majority of these
early programmes were tasked with ex-
ploring the breadth of the protein struc-
tural universe by focussing on prokaryotic
targets whilst driving novel structural
biology technology for a high-throughput
environment [1,6].
New avenues have been opened by the
availability of detailed structural descrip-
tions of proteins and enzymes involved in
the normal (or abnormal) functioning of
the human body and associated patho-
gens. In particular, this information pro-
vides a better understanding of the basis
by which different proteins achieve selec-
tivity and specific binding to their cognate
ligands and drugs [1]. Indeed, several
marketed drugs in recent years have been
developed using structure-based methods,
targeting a wide range of disease such as
AIDS, leukaemia, cancers and venous
thromboembolic events [1,7–10].
Despite these successes, determining the
structures of human proteins in a high-
throughput manner was seen to be
technically challenging relative to those
of less complex organisms (e.g. prokary-
otes), where issues such as the lack of
solubility of expressed proteins in simple
bacterial systems pose major bottlenecks to
scaling the structure determination process
[11]. The SGC (http://www.thesgc.org)
was created in 2003 as a response to this
challenge.
The SGC is a not-for-profit organisa-
tion that aims to solve the three dimen-
sional structures of proteins of medical
relevance and place them into the public
domain without encumbrance or restric-
tion. The SGC has adopted a protein-
family based approach whereby protein
targets are chosen from discrete and
medically-relevant human protein fami-
lies. This approach ensures that compar-
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be applied to members of same family
[11]. The SGC is driving the concept of
‘‘open-source science’’ to enable drug
discovery by promoting pre-competitive
structural biology and medicinal chemis-
try. This is achieved by combining aca-
demic and industrial efforts to create
open-access chemical and clinical probes
[12–14] which might be used in a pre-
competitive manner for target validation
purposes, for example.
Since the production phase of the SGC
began in 2004, we have released the
coordinates of over 800 protein structures
related to several diseases and metabolic
disorders into the public domain of which
over 700 are novel and unique. Whilst the
SGC focuses primarily on human targets,
we also pursue the structure determination
of proteins from parasitic organisms asso-
ciated with neglected diseases, such as
malaria and toxoplasmosis. We have
deposited more than 70 of these structures
into the public domain. These structures
are providing a significant impact with the
SGC providing 61% of publicly available
apicomplexan structures. The SGC has
also developed new protocols and methods
that are now widely used [15–18] and is
developing chemical probes [19] and small
molecules in areas such as human epige-
netics and human protein kinases, to be
placed in the public domain [1] as part of
the ‘open-source’ science approach.
In this PLoS ONE Collection we
present articles covering the structure
determination of a number of targets by
the SGC along with additional work
carried out to further characterise these
proteins. Since SG data is intrinsically
heterogeneous and not always accessible
to non-specialists, all the articles from this
collection are available also as an en-
hanced version using our interactive
visualisation platform – known as iSee –
which allows the reader to interact and
manipulate the 3D scenes prepared by the
authors to highlight and support informa-
tion given in the main text of the article
[20].
SGC and iSee: extending the
delivery of structural biology
data
A clear mandate of the SGC is to make
results readily available to the scientific
community. This data is necessarily het-
erogeneous in nature, ranging from mate-
rials and methods, construct and clone
design, protein expression and purification
to small molecule screening and protein
structure determination information. The
primary ‘customers’ for this information
are not necessarily structural biologists but
scientists with little if any structural
biology understanding such as medicinal
chemists, clinicians, pathologists etc.
Historically, SG efforts have solved
structures of proteins with unknown func-
tion, relying on the scientific community to
take these proteins, characterise them
annotate the structures. Sincethe structures
released by the SGC are of targets with
known biochemical and, often, biological
function, it is possible to interpret the
structures in these contexts thereby provid-
ing new insights into the role of the targets.
However, the deposition into specialist
databases such as the Protein Data Bank
of the protein structures is not sufficient to
reach the ‘customers’ of this data. There
are a number of significant challenges that
face an interested scientist who is not a
structural biologist. Firstly, the scientist
must be aware of where and how a protein
structure can be retrieved. Secondly, it is
necessary to visualise the structure using
software that may not be intuitive to a non
structural-biologist. Thirdly, the interpre-
tation of the structure is dependent not
only on an understanding of the biology
and function of the protein, but also the
structure itself. Alternatively, protein struc-
tures may be published in peer-reviewed
journals. However, this medium often
suffers from stringent restrictions in size
by the publishers, forcing the authors to
use jargon and cutting down the elemen-
tary information needed for the compre-
hension by non-structural biologist.
Representing a 3D protein structure
using media that is in reality 2D also poses
an obstacle. The visualisation of protein
structure on a computer screen is a clear
improvement over a paper figure, even if
stereo images are provided. Several movie-
making tools (e.g. PMG [21], eMovie [22],
VMD [23], MovieMaker [24], POLY-
VIEW-3D [25], YASARA movie (http://
www.yasara.org)) are an alternative to
convey a sense of depth and perspective
to structures. However, this approach
provides ‘fixed’ set of visualisations as
defined by the movie authors resulting
the viewer being unable to interact with
the structure displayed. This hurdle is
overcome using specialist visualisation
software (e.g. PyMol (http://www.pymol.
org), Jmol (http://jmol.sourceforge.net),
Kinemage/KiNG [26,27], Swiss PDB
Viewer [28], FirstGlance (http://molvis.
sdsc.edu/fgij), RCSB Protein Workshop
[29]). Some of these platforms are feature-
rich from the perspective of a structural
biologist making them somewhat inacces-
sible and unintuitive to use by others.
Others are simple to use but at the cost of
functionality and the ability to replicate,
for example, figures produced in peer-
reviewed articles.
The SGC is unable to write and publish
papers on every structure we solve but yet
needs to provide results to the widest
audience possible. Given this, we recog-
nised that an intuitive solution to the
aforementioned issues would be to com-
bine expert-written explanatory text with
relevant portions linked to pre-staged
scenes, using the underlying data, to
illustrate the points being made. Impor-
tantly, these pre-staged views should be
able to be invoked in any order in a
seamless fashion and allow the reader to
manipulate the visualisation as they see fit.
The resulting platform is known as iSee
was launched in 2005. iSee integrates key
data from all stages of the high throughput
structural biology pipeline, from cloning
details and molecular biology/protein
chemistry protocols to the full coordinates
of the solved structures. The structural
information is discussed, visualised and
annotated by experts of the protein
families within the SGC, focussing on
making the results as accessible as possible
to a wide range of readers [20].
The iSee concept was implemented
using Molsoft’s ICM platform [30], as this
was the most mature platform available for
this approach at the time. ICM is used to
bundle a large number of heterogeneous
data types together as a single, small
computer file (please refer to the 3D
document overview article by Abagyan et
al. in this Collection for more details) and
provide high quality graphical visualisa-
tions of that data. Each file – which we dub
an ‘iSee datapack’ – is usually smaller than
10 Mb and can be downloaded freely from
the SGC website (www.thesgc.org/iSee).
To open these datapacks online, a free
plugin is available for the most common
internet browsers and platforms such as
Windows, Linux and Mac OS/X with
Internet Explorer, Mozilla Firefox, Google
Chrome and Safari (Figure 1). An offline
standalone free reader is also available,
known as ICM Browser (Figure 2).
A datapack is made up of two major
interface components: an annotation text
pane corresponding to the textual element
of a paper, and a graphical pane where
high-quality 3D visualisations are shown
(Figure 3). Within the text words or
phrases are linked, in the style of web
hyperlinks, to the triggering of an anima-
tion or transition to a pre-programmed
scene in the graphical pane depicting
important structural features which are
discussed in the text. Each of these scenes
Overview - the SGC Collection
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prepared by the datapack’s author in
conjunction with the text. Since there is
no physical space limit on the number of
these slides, the datapacks have signifi-
cantly more ‘figures’ embedded than is
generally found in traditional papers.
Furthermore, these Figures are only the
starting points for readers who are then
able to interactively adjust the view and
capture its three dimensional complexity.
Successive clicks on different links trigger
animated transitions, which are computed
‘on-the-fly’, from one scene to another,
helping the reader to maintain context
within in the structure and establish the
spatial relationship between features. Im-
portantly, the ability to calculate transi-
tions upon request means that the reader
has direct control over the flow of reading
as the links can be clicked on in any order
desired. All these features are implement-
ed in the program ICM (www.molsoft.
com; [30]), in a user-friendly way, to
enable scientists outside SGC to easily
create their own iSee-like datapacks.
Each SGC iSee datapack is target-
centric, making datapacks a one-stop shop
for SGC data for a given target. Where
there are multiple structures for a target
determined by the SGC, often with differ-
ent co-complexed ligands, these are includ-
ed and frequently compared. Since 2005
the SGC has authored more than 500
datapacks covering more than 600 struc-
tures deposited by the SGC. At the time of
writing, there have been more than 25,000
unique downloads of SGC iSee datapacks.
Since the initial launch of the iSee
concept, several implementations along
similar lines have been launched. For
instance Nature Structural Biology has
adopted a simple linking to an external 3D
visualiser for articles with structures and
associated PDB codes [31].
The Proteopedia initiative [32] employs
the core of the iSee concept, whereby
selected portions of an explanatory text
are linked to interactive scenes. It is
entirely web-based, employing Jmol as
the viewing engine. Its key innovation lies
in the adoption of a community-authored
Wiki model. This allows a readers to find
structures deposited at the PDB and
author annotations to capture key scien-
tific information about the protein.
In September 2008 Kumar et al. [33]
proposedanddemonstrated the embedding
and display of 3D objects within a PDF file.
For the first time in a structural biology
publication they utilised a pre-existing
feature of the Adobe Acrobat package that
has been little-known to the biomedical
community (but commonly used by CAD/
engineering communities). Unfortunately,
the process to produce embedded 3D
objects within a PDF is non-trivial in the
context of structural biology data and so far
(to our knowledge) only the author’s article
has been published using this method.
Moreover all the 3D objects using this
format are merely described as surfaces and
do not retain any of the underlying
scientific information from the original
structural data, making it suitable for
simple viewing only. This is because the
use of surfaces means that, apart from
colour changes and viewpoints, every new
Figure 1. Reading the iSee version of the articles on-line - first-time installation instructions.
doi:10.1371/journal.pone.0007675.g001
Overview - the SGC Collection
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novel surfaces, at the expense of file size.
Recently publishers have indicated their
awareness and desire to explore this field
further. The initiative from Cell Press and
Elsevier entitled ‘Article of the Future’
(http://beta.cell.com) explores the advan-
tages of various modes in which a web-
based publication of the future may be
delivered. The Journal of Biological Chem-
istry also encourages the use of 3D PDFs to
communicate structural information [34].
We welcome these initiatives and expect
that more will come to light as the demands
of authors and readerships change, aligning
closely with our iSee concept.
The PLoS ONE Collection: peer-
reviewing iSee datapacks
The PLoS ONE Collection, entitled
‘Structural Biology and Human Health:
Medically Relevant Proteins from the
SGC’ contains a continually expanding
series of articles documenting many of the
novel protein structures determined by the
SGC and work to further characterise
their function. In addition to the standard
PLoS ONE online delivery mechanism,
each article is available as an online iSee
datapack, enabling the delivery of our data
in an interactive and intuitive 3D manner.
A ni m p o r t a n ta s p e c to ft h i sP L o SO N E
Collection is that, for the first time in an
open-access journal, the peer-review pro-
cess of these articles is carried out upon
t h ee n h a n c e dn o n - p a p e rb a s e di S e e
datapack versions themselves. We believe
that this allows reviewers to take advan-
tage of the information integrated in a
single file, in addition to the 3D data
including live 2D data attachments such
as chemical or standard spreadsheets and
plots, alignments, etc. Additionally, this
also saves the referees’ time in that there
is no immediate need to retrieve, analyse
and validate the structural data, for these
are all included in the iSee datapack
itself.
We have also made the iSee version of
our articles open-access, using the Creative
Commons Attribution license in common
with all PLoS ONE articles, ensuring that
the full content can be further extended if
any reader wishes to do so. This allows other
organisationsto captureand even extend the
information published in the articles and
integrate it into novel platforms.
Further discussion and feedback of our
articles is encouraged and enabled on the
PLoS ONE website. Both the HTML/PDF
and the enhanced iSee versions will remain
constant in terms of content and location.
This is critically important for future refer-
ence and also archival purposes. Fortechnical
questions and feedback we have implement-
ed an iSee-Wiki (http://www.thesgc.org/
iSee/wiki) maintained by specialists to ad-
dress the most common questions and to
provide usage and authoring tips.
Three-dimensional documents -
the future
Currently, iSee datapacks are provided in
a binary file format to enable maximal
compactness and fast download to the
browser. A full text file format would
increase the files’ size resulting in relatively
slow downloads into the browser/plugin.
However we strongly believe that it is vital
Figure 2. Reading the iSee version of the articles offline - first-time installation instructions.
doi:10.1371/journal.pone.0007675.g002
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similar data and its interpretation in a
completely open manner. Not only is this
important for the ability to curate and
archive such work, it is also critical to allow
the data to be opened and displayed in other
visualisation platforms. To enable the por-
table delivery of such content we are
working with the structural biology visual-
isation community to begin work on an
open fileformat which can provide a human
readable and editable version of any set of
data, visualisations and annotations.
Conclusion
We are excited to be making the SGC’s
work available to a greater audience via
this PLoS ONE collection. With the use
of iSee as the first example of an
interactive and intuitive 3D document
publication method as part of PLoS
ONE, we are pushing the boundaries of
structural biology data delivery and peer-
review. Our strong hope is that this step
forward will encourage other publishing
houses to consider the need for publica-
tion of three dimensional data in a similar
manner.
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